133 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
of Law; Increased Costs. In the event that any applicable Change in Law:
(a)Does or shall subject any Lender to any Tax of any kind whatsoever … on account of, any Tax imposed, levied, collected, withheld or assessed by any Governmental Authority. In addition, Borrower agrees to pay, and shall
8-K/A
EX-10.2
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
Indemnity
Section 8.2
Notice of Claims
Section 8.3
Limitations on Liability
Section 8.4
Third Party Claims
Section 8.5
Exclusive Remedy
Section 8.6
Tax … of the applicable Person and maintained in conformity with GAAP, if required; provided, further, that in the case of a Tax, assessment or charge that has
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
9 May 24
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
4:17pm
Other income (expense), net
Income (loss) before income taxes
Income tax provision
Net income (loss) per share:
Basic
Diluted
Weighted-average number
8-K
EX-99.1
ypb51xnmpw
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
8-K
EX-99.2
zty0z58fbhol8o819y
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
8-K
EX-2.1
mrr76et
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
EX-99.1
bgu9wj7bfcet3qsto
6 Nov 23
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
4:31pm
8-K/A
EX-99.1
wl5tamakx75r5e
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K/A
EX-99.2
5c2w7y
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
424B5
2ig7u ew7a
12 Sep 23
Prospectus supplement for primary offering
6:04am
8-K
EX-99.1
6hfv2r
2 Aug 23
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
4:05pm